Two bone-conduction hearing aids (BCHAs) could deliver improved stereo separation using cross-talk cancellation. Sound vibrations from each BCHA would be cancelled at the contralateral cochlea by an out-of-phase signal of the same level from the ipsilateral BCHA. A method to measure the level and phase required for these cancellation signals was developed and cross-validated with an established technique that combines air- and bone-conducted sound. Three participants with normal hearing wore bone transducers (BTs) on each mastoid and insert earphones. Both BTs produced a pure tone and the level and phase were adjusted in the right BT in order to cancel all perceived sound at that ear. To cross-validate, one BT was stimulated with a pure tone and participants cancelled the resultant signal at both cochleae via adjustment of the phase and level of signals from the earphones. Participants achieved cancellation using both methods between 1.5 and 8 kHz. Levels measured with each method differed by <1 dB between 3 and 5 kHz. The phase results also corresponded well for the cancelled ear (11° mean difference) but poorly for the contralateral ear (38.4° mean difference). The first method is transferable to patients with middle-ear dysfunction, but covers a limited frequency range.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1121/1.5131650 | DOI Listing |
J Med Internet Res
January 2025
Institute of Medical Teaching and Medical Education Research, University Hospital Würzburg, Würzburg, Germany.
Background: Objective structured clinical examinations (OSCEs) are a widely recognized and accepted method to assess clinical competencies but are often resource-intensive.
Objective: This study aimed to evaluate the feasibility and effectiveness of a virtual reality (VR)-based station (VRS) compared with a traditional physical station (PHS) in an already established curricular OSCE.
Methods: Fifth-year medical students participated in an OSCE consisting of 10 stations.
PLoS Pathog
January 2025
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
The latent viral reservoir remains the major barrier to HIV cure, placing the burden of strict adherence to antiretroviral therapy (ART) on people living with HIV to prevent recrudescence of viremia. For infants with perinatally acquired HIV, adherence is anticipated to be a lifelong need. In this study, we tested the hypothesis that administration of ART and viral Envelope-specific rhesus-derived IgG1 monoclonal antibodies (RhmAbs) with or without the IL-15 superagonist N-803 early in infection would limit viral reservoir establishment in SIV-infected infant rhesus macaques.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
The First Medical Center of Chinese PLA General Hospital & Medical School, Beijing, China.
Background: This study investigates the role and efficacy of acupuncture combined with rehabilitation therapy during the recovery phase of patients with traumatic spinal cord injury. Patients hospitalized in the acupuncture department of our center between December 1, 2019, and December 1, 2021, were enrolled.
Methods: Participants were divided into an observation group (acupuncture and rehabilitation therapy) and a control group (rehabilitation therapy alone) based on their treatment sequence.
Clin Cancer Res
January 2025
University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Purpose: Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that is essential for the survival and immune sequestration of cancer cells. We conducted a phase 1 study of TTI‑101, a first-in-class, selective small-molecule inhibitor of STAT3, in patients with advanced metastatic cancer.
Patients And Methods: Patients were treated with TTI-101 orally twice daily in 28-day cycles at 4 dose levels (DLs): 3.
J Infect Dis
January 2025
Moderna, Inc., Cambridge, MA 02142, USA.
Background: mRNA-1283 is an investigational COVID-19 mRNA vaccine encoding the receptor-binding and N-terminal domains of the SARS-CoV-2 spike protein in contrast to the original mRNA-1273, which encodes the full-length spike protein.
Methods: A phase 2a, dose-ranging, observer-blind, randomized study (NCT05137236) conducted in adults (≥18 years) previously vaccinated with mRNA-1273 evaluated the safety and immunogenicity of a single dose of mRNA-1283 (2.5, 5, and 10 µg) and its bivalent formulation, mRNA-1283.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!